Working… Menu

Double Blind Phase III Trial of Effects of Low Dose 13-Cisretinoic Acid on Prevention of Second Primaries in Stages I-II Head and Neck Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03370367
Recruitment Status : Completed
First Posted : December 12, 2017
Last Update Posted : September 16, 2019
Information provided by (Responsible Party):
Eastern Cooperative Oncology Group

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : January 15, 1999
Actual Study Completion Date : April 14, 2015